Updating the natural history of human papillomavirus and anogenital cancers
about
Cytoplasmic vacuolization in cell death and survivalMate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral EtiologyEUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infectionTrends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012Human papillomavirus and gastrointestinal cancer: A reviewSkin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic ApproachesGenital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology.Identification of episomal human papillomavirus and other DNA viruses in cytological anal samples of HIV-uninfected men who have sex with men.The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results.Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma.Comprehensive control of human papillomavirus infections and related diseasesClearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients.The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.Human papillomavirus 16E6 and NFX1-123 potentiate Notch signaling and differentiation without activating cellular arrestSecond-generation prophylactic HPV vaccines: successes and challenges.Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.Distribution of cervical intraepithelial neoplasia on the cervix in Chinese women: pooled analysis of 19 population based screening studies.RNA Binding Proteins that Control Human Papillomavirus Gene Expression.Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women.Cytological Anal Squamous Intraepithelial Lesions Associated with Anal High-Risk Human Papillomavirus Infections among Men Who Have Sex with Men in Northern Thailand.Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.Age and HPV type as risk factors for HPV persistence after loop excision in patients with high grade cervical lesions: an observational study.Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.Progression or Regression? - Strengths and Weaknesses of the New Munich Nomenclature III for Cervix CytologyHigh Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7Human papillomavirus variants among Inuit women in northern Quebec, Canada.Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women.Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study.Human Papillomavirus Laboratory Testing: the Changing ParadigmUS assessment of HPV types in cancers: implications for current and 9-valent HPV vaccinesmiR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6A comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancerAnal human papillomavirus infection among HIV-infected and uninfected men who have sex with men in Beijing, ChinaCUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining.Human papillomavirus infections in nonsexually active perinatally HIV infected children
P2860
Q26743410-A7BE4018-3884-4A40-A896-A55739A002CFQ26799320-A40F916A-8D0B-466F-A5A2-47076430AD57Q27010432-1B32121A-50C9-4EA0-A195-D052C9CE2B1BQ27312453-4844100C-A641-460D-8ECB-1B27108F3CA1Q28069930-572D973A-2A21-4E22-8057-4261E207EA09Q30238649-D08D6F82-2208-460F-BB1A-7031CC86E3C6Q30279220-DE09B6DF-AE56-4935-AE6D-4B5B3E82658DQ30794549-2F13D13F-1DF5-45E6-BF7E-193E49AE74F6Q31126565-7EFEC325-DC92-4099-B85A-6F5AAADCD783Q33585203-B9D26EB8-E74B-4964-A9A2-D63511E8F7B1Q33589738-DEE57AD3-4F84-46A8-A4C5-74D65D86FFF0Q33665786-528AA276-E368-4436-B766-355DD1BF6866Q33729819-973DC2AE-429F-4AE9-961E-75B633CB46D3Q33772648-F77095C0-64EF-4FAB-AB10-78A8A54383A5Q34453827-BB19BBC6-79C2-44C5-9A60-410BE3D62692Q35038766-9CC4A4D8-94E4-4A71-8C26-7C9A40E81A40Q35221196-2558BBDC-78DD-4F43-9057-392F3DBFE599Q35248947-A38FBE77-C6E5-462A-8350-5FCEADA751C4Q35541886-8E4B72F1-80E5-4BCA-87C1-76246968254CQ35665790-D02B4AE4-2646-4BE6-B392-BD4C6A9059FDQ35677569-966B215B-E083-402F-B0AE-48E48A7AAF79Q35834013-B1AB9749-D9C5-4682-86DB-E3188E65DDE0Q36015006-E93A15AB-0F40-4291-ABD9-BA7B74DB8EB4Q36030245-8210DD81-257A-4224-B0B5-C2274EC933F3Q36116209-5CD967AE-84E9-41C6-AAED-D1F6EA8640C3Q36157210-8DA56BD6-7434-47C3-9819-4C4C823ABC79Q36208231-08976594-3A0C-4B06-A31B-FD21741512EDQ36240023-01B34E28-B1E4-492A-92BD-1FA9100A31D7Q36240353-99195B49-33F2-43E5-A82E-2A0C25856CAAQ36417526-F374287D-DDCB-4F69-B87F-5D17D17E7027Q36565494-F53A82D1-94A5-4DAE-8A03-CF7032353B02Q36571067-DC5B6890-1A56-49CB-BC49-E32B76A9F07CQ36675236-C85CE661-1B5A-4475-B492-E972B86F7BEAQ36817074-28AD673E-2608-4320-B98D-F6D84474103AQ37057240-6A3D6548-C26A-4EBE-81CA-A1B18BAF1D5CQ37131721-DB719A2D-1A2F-4847-AD2F-19573B0B769CQ37190554-FF91EC5B-D518-4B8D-A785-FB225A1B8F35Q37327810-DB31D86F-7E2C-4659-AEE7-756B33E05232Q37569565-5C8216F3-74D4-46DF-985B-DA023A680705Q37587903-5FAA51A3-4C55-420A-AD19-E753FE9517E6
P2860
Updating the natural history of human papillomavirus and anogenital cancers
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Updating the natural history of human papillomavirus and anogenital cancers
@en
type
label
Updating the natural history of human papillomavirus and anogenital cancers
@en
prefLabel
Updating the natural history of human papillomavirus and anogenital cancers
@en
P2093
P2860
P50
P1433
P1476
Updating the natural history of human papillomavirus and anogenital cancers
@en
P2093
Ann Burchell
Anna R Giuliano
Anna-Barbara Moscicki
Joel Palefsky
Marc T Goodman
P2860
P304
P356
10.1016/J.VACCINE.2012.05.089
P407
P478
30 Suppl 5
P577
2012-11-01T00:00:00Z